云南高校图书馆联盟文献共享服务平台- DARBEPOETIN

DARBEPOETIN: 作品数：10被引量：10H指数：2; 导出分析报告; 相关领域：医药卫生文化科学更多>>; 相关作者：周成慧彭佑铭邵瑞奇冯琰更多>>; 相关机构：中南大学中南大学湘雅二医院河北体育学院沈阳体育学院更多>>; 相关期刊：《World Journal of Gastroenterology》《Pharmacology & Pharmacy》《国外药讯》《世界临床药物》更多>>

Hemoglobin Level Stability after a Switch from Darbepoetin Alfa to Epoetin Beta Pegol for the Treatment of Renal Anemia in Hemodialysis Patients: 《International Journal of Clinical Medicine》2015年第9期652-660,共9页Sayaka Takahashi Yoshiko Tanaka Mari Takano Keiko Suzuki Mio Ueda Yukiko Shimamoto Kosaku Nitta; Background: New erythropoiesis-stimulating agents (ESAs) with a longer half-life have been developed for the treatment of anemia as a complication of patients with end-stage renal disease. Objectives: The objective of...; 关键词：DARBEPOETIN ALFA EPOETIN Beta Pegol HEMOGLOBIN ESA Resistance HEMODIALYSIS

Improved Recovery of Erythropoietin and Darbepoetin from Equine Plasma by the Application of a Wheat Germ Agglutinin Mediated Pre-Extraction Prior to Immunoaffinity Chromatography: 《Advances in Bioscience and Biotechnology》2014年第7期651-660,共10页Shawn M. R. Stanley Danny Chua; We describe a two-step method that uses wheat germ agglutinin immobilized on Sepharose gel followed by immunoaffinity chromatography (IAC) to extract recombinant human erythropoietin and Darbepoetin from equine plasma...; 关键词：ERYTHROPOIETIN DARBEPOETIN Alfa IMMUNOAFFINITY EXTRACTION Lectin Affinity EXTRACTION Wheat GERM AGGLUTININ Horseracing

Effects of Darbepoetin-<i>α</i>on Oxidative Stress Marker in Patients with Chronic Renal Failure: 《Open Journal of Nephrology》2014年第1期8-12,共5页Norio Nakamura Michiko Shimada Ikuyo Narita Yuko Shimaya Takeshi Fujita Reiichi Murakami Hiroshi Osawa Hideaki Yamabe Ken Okumura; Objective: Long-acting darbepoetin-α (DA) has recently been used to treat renal anemia in patients with chronic renal failure. It is considered clinically useful because its duration of action is longer than that of ...; 关键词：Chronic RENAL Failure Darbepoetin-α Epoetin-α Indoxyl SULFATE MDA-LDL RENAL ANEMIA

Pharmacodynamics of CNTO 530 and Darbepoetin-α in Human TNF-α Transgenic Mice, a Murine Model of Anemia of Chronic Disease: 《Pharmacology & Pharmacy》2011年第1期17-30,共14页Ram Achuthanandam Dorie Makropoulos Laura Johns Amy Volk Kerry Brosnan Jin Lu Wojciech Krzyzanski Peter J. Bugelski; CNTO 530 and darbepoetin-a are long lived erythropoietin receptor agonists (ERAs). Clinically, anemia of chronic disease (ACD) is associated with increased expression of tumor necrosis factor-a (TNF-a) and mice transg...; 关键词：Fusion Protein RECOMBINANT Flow CYTOMETRY ERYTHROPOIESIS

Use of agents stimulating erythropoiesis in digestive diseases被引量：2: 《World Journal of Gastroenterology》2009年第37期4675-4685,共11页Rosario Moreno López Beatriz Sicilia Aladrén Fernando Gomollón García; Anemia is the most common complication of inflammatory bowel disease (IBD). Control and inadequate treatment leads to a worse quality of life and increased morbidity and hospitalization. Blood loss, and to a lesser ex...; 关键词：Erythropoiesis-stimulating agents Recom-binant human erythropoietin DARBEPOETIN Continuous erythropoietin receptor activator Inflammatory bowel disease ANEMIA

Darbepoetin α对有症状性慢性心力衰竭伴贫血患者运动耐量的影响:一项随机、双盲、安慰剂对照试验被引量：4: 《世界核心医学期刊文摘（心脏病学分册）》2007年第7期59-60,共2页Ponikowski P. Anker S.D. Szachniewicz J. K.McDonald 韩瑞娟; 目的：本研究旨在观察darbepoetin α（一种红细胞生成刺激蛋白，ESP）能否改善有症状性慢性心力衰竭（CHF）伴贫血患者的运动耐量。背景：贫血在CHF患者中较为常见。方法：在此项多中心、随机、双盲、安慰剂对照研究中，伴有贫血（血...; 关键词：慢性心力衰竭安慰剂对照贫血患者运动耐量症状性对照试验随机双盲

依泊汀与darbepoetin之间“没有差别”: 《国外药讯》2007年第1期33-34,共2页金伟秋（摘）; 由美国保健研究与质量管理局（AHRQ）资助，蓝十字会与蓝盾协会技术评估中心循证实践中心进行的一项研究报告发现，在癌症化疗引起的贫血治疗中，依泊汀α（epoetin-alfa，Amgen公司的Epogen和J＆J公司的Procrit）（Ⅰ）与darbepoetin-...; 关键词：dar Amgen公司保健项目安全性指标 J&J公司血栓栓塞性质量管理循证实践

Darbepoetinα治疗慢性肾衰竭引发的贫血被引量：3: 《世界临床药物》2005年第2期91-95,共5页周成慧彭佑铭; 新型重组促红细胞生成素darbepoetin α(商品名Aranesp)是一种新型红细胞刺激蛋白,能有效安全地治疗透析或未透析慢性肾衰竭患者的贫血,本文对其结构功能、药动学特点及临床疗效、不良反应等方面作一综述。; 关键词：DARBEPOETIN α 治疗慢性肾衰竭贫血药动学

新型EPO类兴奋剂——Darbepoetin被引量：1: 《辽宁体育科技》2004年第3期30-31,共2页邵瑞奇冯琰; 通过对新型EPO类兴奋剂——Darbepoetin(也称NESP，Aranesp)的结构、药动学特征、临床应用情况及其滥用危害性的介绍，进而推进我国反兴奋剂工作的进程。; 关键词：兴奋剂促红细胞生成素(EPO) Darbepoetin(NESP Aranesp)

慢性肾病患者可应用Darbepootin α隔周1次治疗贫血: 《国外医学（内科学分册）》2003年第3期138-138,共1页文映碧; Darbepoetin α是一种红细胞生成刺激蛋白,它与重组人促红细胞生成素(rHuEPO)的作用机制相同,而血清半衰期长2倍。作者在慢性肾病无需血液透析拟用rHuEPo治疗的患者,用Darbepoetin α隔周1次以延长给药间隔时间,评估对贫血的治疗作用。; 关键词：慢性肾病 Darbepoetinα 治疗贫血

DARBEPOETIN